Lupin submits marketing authorization application for Etanercept biosimilar in Europe Ruby Khatun Khatun27 May 2018 10:15 AM ISTMumbai: Pharma major Lupin announced that its Marketing Authorization Application (MAA) for a biosimilar of Etanercept has been accepted for review by...
Johnson and Johnson jury asks judge to slap cancer warning on baby powder: Report Ruby Khatun Khatun27 May 2018 10:00 AM ISTIf Johnson and Johnson (J&J) won’t put a warning on its baby powder that it may be tainted with asbestos, some jurors were ready to do it for...
Zydus Wellness Q4 net rises 22 percent to Rs 36 crore Ruby Khatun Khatun27 May 2018 9:45 AM ISTNew Delhi: Zydus Wellness reported a 21.93 percent increase in consolidated net profit at Rs 36.25 crore for the quarter ended March 2018.The company...
AstraZeneca cancer drug hits second goal by extending survival Ruby Khatun Khatun27 May 2018 9:30 AM ISTLONDON: AstraZeneca’s immunotherapy drug Imfinzi has hit a second important goal by improving overall survival in lung cancer patients, boosting...
Australian anti-trust watchdog loses appeal against Pfizer over Lipitor sales Ruby Khatun Khatun27 May 2018 9:15 AM ISTMELBOURNE: An Australian court dismissed an appeal by the nation’s anti-trust watchdog in a case against Pfizer Inc in which the regulator alleged the...
Zydus Cadila gets USFDA nod for prostate drug Ruby Khatun Khatun26 May 2018 10:45 AM ISTNew Delhi: Zydus Cadila has received final approval from the US health regulator to market Dutasteride and Tamsulosin Hydrochloride capsules.The drug...
Sun Pharma Q4 net up 7 percent at Rs 1,309 crore Ruby Khatun Khatun26 May 2018 10:30 AM ISTNew Delhi: Drug major Sun Pharma posted 6.96 percent increase in its consolidated net profit at Rs 1,308.96 crore for the fourth quarter ended March...
Pfizer to pay 23.85 million dollar to settle US co-payment kickback probe Ruby Khatun Khatun26 May 2018 10:15 AM ISTPfizer Inc agreed to pay $23.85 million to resolve U.S. charges that it used a purportedly independent charity to pay illegal kickbacks to Medicare...
IHH Healthcare extends validity of revised offer for Fortis to June 30 Ruby Khatun Khatun26 May 2018 10:00 AM ISTNew Delhi: Malaysian firm IHH Healthcare Berhard on Friday extended the acceptance period for its enhanced revised proposal for acquiring Fortis to...
FDA approves BioMarin rare metabolic disorder drug Ruby Khatun Khatun26 May 2018 9:45 AM ISTU.S. regulators approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare metabolic disorder, sending shares of the...
Novartis receives EU approval for biosimilar Zessly Ruby Khatun Khatun26 May 2018 9:30 AM ISTZURICH: Novartis said its Sandoz division received approval from the European Commission for its biosimilar Zessly (infliximab) in...
Manipal-TPG combine extends validity of revised offer for Fortis Ruby Khatun Khatun25 May 2018 10:40 AM ISTNew Delhi: Manipal-TPG combine has said it has extended the validity of its modified offer for Fortis Healthcare to June 6, 2018.On May 17, Malaysian...
